Showing results (201-210 of 227) with videos related to
Sort By:
Pageof 23
Clinical Epigenetics|July 16, 2025
Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemiaHaeun Yang, Vladimir Li, Su Jung Park, et al.Annals of Neurology|August 6, 2010
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trialRik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, et al.EJNMMI Research|June 1, 2023
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsLennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, et al.EJNMMI Radiopharmacy and Chemistry|January 28, 2021
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020)Mohammed Al-Qahtani, Martin Behe, Guy Bormans, et al.Journal of Neuroendocrinology|June 5, 2024
Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trialHannes Leupe, Elin Pauwels, Timon Vandamme, et al.Molecular Imaging and Biology|May 22, 2019
Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary TanglesMichel Koole, Talakad G Lohith, John L Valentine, et al.Lancet (London, England)|January 18, 2006
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialStefan Janssens, Christophe Dubois, Jan Bogaert, et al.Neurobiology of Aging|January 21, 2015
Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectorsAnke Van der Perren, Jaan Toelen, Cindy Casteels, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2016
Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman PrimatesDieter Ory, Sofie Celen, Rik Gijsbers, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2013
(11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonistsKoenraad J Van Laere, Sandra M Sanabria-Bohórquez, David P Mozley, et al.Pageof 23